Martha Rosenberg

Evanston

Investigative Health Reporter at Freelance

Martha Rosenberg is an investigative health reporter whose work has appeared in the British Medical Journal (BMJ), Consumer Reports, Public Citizen and more

Featured in: Favicon

huffpost.com Favicon

businessinsider.com Favicon

sfgate.com Favicon

bmj.com

salon.com

suntimes.com Favicon

theepochtimes.com Favicon

rawstory.com Favicon

morningstar.com Favicon

globalresearch.ca + 96 more

Articles

How will US tariffs affect the pharmaceutical industry?

6 days ago | mainstreamweekly.net | Martha Rosenberg

Drugmakers in the US have been exempted from tariffs but the pills and capsules may soon hit the fan. They are lobbying US president Donald Trump for more time to absorb tariffs and perhaps move their manufacturing sites according to published reports. Many realize the trillion dollar a year Pharma industry has “captured “the US Food and Drug Administration or FDA, the US Congress with its lobbyists and US news sites with ad revenue. The outgoing Commission had 51 financial Pharma links).
Conflicts of interest are eroding trust in U.S. health agencies

1 week ago | kevinmd.com | Martha Rosenberg |Leslie Gregory |Paul Pender |Nina Cloven

Why has faith in government health agencies never been lower? Because conflicts of interest (COIs) have never been higher. At the FDA, concerns about drugmakers “buying” drug approvals go back to passage of the Prescription Drug User Fee Act (PDUFA) in . Since then, the many doctors with research and speaker grants, drug stocks, and past employment with drugmakers heighten concerns.
What Will Happen to Federal Meat Inspectors Ask Health and Animal Advocates?

1 week ago | f.mtr.cool | Martha Rosenberg

For more than 20 years, federal meat inspectors, who work for the Food Safety and Inspection Service (FSIS) part of the United States Department of Agriculture (USDA), have highlighted their waning power in meat plants and its effect on the food risks they are charged to prevent. What will happen now? There is a natural antipathy between private meat companies and federal inspectors who can affect the former’s bottom line by stopping the slaughter line and other interventions.
What Will Happen to Federal Meat Inspectors Ask Health and Animal Advocates?

1 week ago | znetwork.org | Martha Rosenberg

For more than 20 years, federal meat inspectors, who work for the Food Safety and Inspection Service (FSIS) part of the United States Department of Agriculture (USDA), have highlighted their waning power in meat plants and its effect on the food risks they are charged to prevent. What will happen now? There is a natural antipathy between private meat companies and federal inspectors who can affect the former’s bottom line by stopping the slaughter line and other interventions.
Staying stone free with AI: How smart tech is revolutionizing kidney stone prevention

2 weeks ago | kevinmd.com | Robert Chan |Christopher Medrano |Martha Rosenberg |Andrew Williams

Kidney stones are painful, frustrating, and unfortunately common. I see this brutal problem every day as a urologist. When my wife had her first kidney stone while celebrating her 40th birthday, this issue became deeply personal. Seeing her in pain and struggling to navigate the confusing world of kidney stone prevention made me realize just how difficult this journey is for patients.
Why the FDA's outdated prescription rules hinder access to birth control and naloxone [PODCAST]

4 weeks ago | kevinmd.com | Leah Hampson Yoke |Martha Rosenberg |Robert J. Trent

Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes!Surgeon and author Jeffrey A. Singer discusses his article “The FDA’s outdated prescription rules are failing women and opioid users.” He argues that the U.S. Food and Drug Administration’s requirement for prescriptions for certain safe medications, specifically hormonal contraceptives and the opioid antidote naloxone, creates significant barriers to access and reflects outdated paternalism.
Reforming the 340B drug discount program through data, clarity, and collaboration [PODCAST]

4 weeks ago | kevinmd.com | Julie Craig |Katya Korol |Sarah Fraser |Martha Rosenberg

Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes!Health care executive Gavin Magaha discusses his article “Advancing drug discount programs starts with collaboration and clarity.” He outlines how the 340B drug discount program, established over 30 years ago, has not evolved with modern health care delivery, leading to complexity, poorly defined standards, compliance issues, and misaligned incentives that hinder its original intent to serve vulnerable patients.
ADHD isn’t one-size-fits-all: Why nuance in diagnosis matters

1 month ago | kevinmd.com | Maire Daugharty |Dawn Baker |Martha Rosenberg |Michele Luckenbaugh

I read with great interest the recently published article in The New York Times by Paul Tough, who has reported on child development and education over the last twenty years. He outlines statistics, specifically the rise in diagnosis of children and adults since the 1990s, and then discusses implications, including questioning a current understanding of the disorder and its treatment.
Can Photos Change Our Eating and Buying Habits and Politics?

1 month ago | counterpunch.org | Martha Rosenberg

The year was 1975. Actress Sally Struthers had charmed her way into America’s living rooms as Gloria Stivic Archie Bunker’s daughter on the hit sitcom All In the Family, married to “meathead.” But Struthers was known for something else. More prevalent than her appearances on All in the Family were her cloying pitches for the Christian Children’s Fund for which she was trying to use her “Family” fame.
Cancer treatment and sexual health: the conversation we need to have

1 month ago | kevinmd.com | Robert Pearl |Susan Levenstein |Martha Rosenberg |Paul Pender

When we think of cancer treatment, we often focus on the immediate goals: Shrinking tumors, stopping the spread of the disease, and ultimately aiming for a cure. What doesn’t get as much attention, but is just as important, is how cancer treatments can affect a patient’s sexual health and reproductive future. Many cancer patients, particularly younger ones, are often left in the dark about how their treatment could impact their sexual function and fertility.